StockDriftsStockDriftsKukje Pharmaceutical (002720) has 8 disclosed insider purchases and 0 disclosed disposals on record, filed by 3 distinct insiders. Together those filings cover ₩74M ($51K) in reported transaction value. The earliest filing StockDrifts holds for Kukje Pharmaceutical is dated 2024-12-06; the most recent is 2026-07-07. Across these filings the average return since disclosure is -2.81%, measured from each filing date to the latest available close.
| Date | Type | Source | Insider | Position | Shares | Price at filing | Return | Value |
|---|---|---|---|---|---|---|---|---|
| 2026-07-07 | BUY | Market Buy | 김영관 Younggwan Kim | vice president | 2.0K | ₩3,355 | +4.0% | ₩7M ($5K) |
| 2026-06-02 | BUY | Market Buy | 김성규 Seonggyu Kim | Managing Director | 1.5K | ₩3,575 | -4.9% | ₩6M ($4K) |
| 2026-05-29 | BUY | Market Buy | 김성규 Seonggyu Kim | Managing Director | 8.1K | ₩3,690 | -7.9% | ₩30M ($21K) |
| 2026-05-29 | BUY | Market Buy | 김영관 Younggwan Kim | vice president | 2.0K | ₩3,690 | -3.1% | ₩7M ($5K) |
| 2026-05-26 | BUY | Market Buy | 최해성 Haeseong Choi | Managing Director | 1.3K | ₩3,965 | -4.7% | ₩5M ($3K) |
| 2026-05-22 | BUY | Market Buy | 최해성 Haeseong Choi | Managing Director | 1.3K | ₩4,075 | -7.2% | ₩5M ($4K) |
| 2025-09-09 | BUY | Market Buy | 김영관 Younggwan Kim | Managing Director | 2.0K | ₩4,550 | +5.4% | ₩9M ($6K) |
| 2024-12-06 | BUY | Market Buy | 김영관 Younggwan Kim | Managing Director | 1.1K | ₩5,000 | -4.1% | ₩5M ($4K) |
Every trade listed above comes from an official regulatory disclosure. For how StockDrifts scores these disclosures, see the Korea insider signal tier research, or browse every Korean stock we track.